Breaking News Instant updates and real-time market news.

BDX

Becton Dickinson

$218.01

0.735 (0.34%)

, CDLX

Cardlytics

$16.80

-0.5 (-2.89%)

10:39
03/06/18
03/06
10:39
03/06/18
10:39

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) initiated with a Market Perform at BMO Capital. 2. Cardlytics (CDLX) initiated with a Buy at SunTrust, an Overweight at JPMorgan and KeyBanc, a Neutral at BofA/Merrill, and an Outperform at Wells Fargo. 3. iRhythm (IRTC) initiated with an Outperform at BMO Capital. 4. Genocea (GNCA) initiated with an Overweight at Cantor Fitzgerald. 5. Domino's Pizza (DPZ) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

BDX

Becton Dickinson

$218.01

0.735 (0.34%)

CDLX

Cardlytics

$16.80

-0.5 (-2.89%)

IRTC

iRhythm

$63.66

-0.57 (-0.89%)

GNCA

Genocea

$1.03

0.02 (1.98%)

DPZ

Domino's Pizza

$221.25

1.64 (0.75%)

  • 12

    Mar

  • 19

    Mar

  • 30

    May

BDX Becton Dickinson
$218.01

0.735 (0.34%)

01/19/18
BOFA
01/19/18
INITIATION
Target $260
BOFA
Buy
Becton Dickinson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Bob Hopkins reinstated Becton Dickinson with a Buy and $260 price target saying he sees upside to revenue estimates from CR Bard deal synergies.
01/19/18
01/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) reinstated with a Buy at BofA/Merrill. 2. athenahealth (ATHN) initiated with an In Line at Evercore ISI. 3. Corbus Pharmaceuticals (CRBP) initiated with an Outperform at Raymond James. 4. Trade Desk (TTD) initiated with a Buy at Stifel. 5. Intellipharmaceutics (IPCI) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/06/18
PIPR
02/06/18
NO CHANGE
Target $260
PIPR
Overweight
Becton Dickinson price target raised to $260 from $223 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Becton Dickinson to $260 from $223 following "good" Q1 results and guidance that looks conservative. The analyst believes Becton Dickinson is poised to keep grinding out higher results which in turn will keep the stock moving incrementally higher. He reiterates an Overweight rating on the shares.
03/05/18
BMOC
03/05/18
INITIATION
Target $249
BMOC
Market Perform
Becton Dickinson initiated with a Market Perform at BMO Capital
BMO Capital analyst Joanne Wuensch initiated Becton Dickinson with a Market Perform rating and a $249.00 price target.
CDLX Cardlytics
$16.80

-0.5 (-2.89%)

03/06/18
RHCO
03/06/18
INITIATION
Target $25
RHCO
Buy
Cardlytics initiated with a Buy at SunTrust
SunTrust analyst Youssef Squali initiated Cardlytics (CDLX) with a Buy rating and a price target of $25. Squali contends that the discount with which this "leader in the $11B native ad bank market trade" should close once investors become familiar with its "limited inventory, large partnerships and lack of easily identifiable publicly-traded comps", looking beyond the company's longer sales cycle. The analyst also points to Cardlytics pilot partnership with Wells Fargo (WFC) in first party data collection, which could roll out nationwide in 2019 and create more significant revenue growth.
03/06/18
JPMS
03/06/18
INITIATION
Target $23
JPMS
Overweight
Cardlytics initiated with an Overweight at JPMorgan
JPMorgan analyst Doug Anmuth started Cardlytics with an Overweight rating and $23 price target. The company has "valuable purchase intelligence" which "closes the loop" for advertisers and differentiates its from other marketing platforms, Anmuth tells investors in a research note. He expects the Cardlytics' revenue growth to accelerate in 2018 and 2019.
03/06/18
WELS
03/06/18
INITIATION
Target $22
WELS
Outperform
Cardlytics initiated with an Outperform at Wells Fargo
Wells Fargo analyst Timothy Willi started Cardlytics with an Outperform rating and $22 price target. The analyst views the company as a secular play on payment data monetization, digital banking and digital advertising.
03/06/18
BOFA
03/06/18
INITIATION
Target $19
BOFA
Neutral
Cardlytics initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Nat Schindler initiated Cardlytics with a Neutral and $19 price target saying he is cautious on client concentration and limited pricing leverage.
IRTC iRhythm
$63.66

-0.57 (-0.89%)

12/01/17
DOTC
12/01/17
INITIATION
DOTC
Neutral
iRhythm initiated with a Neutral at Dougherty
12/04/17
RBCM
12/04/17
INITIATION
Target $79
RBCM
Outperform
iRhythm initiated with an Outperform at RBC Capital
RBC Capital analyst Glenn Novarro initiated iRhythm with an Outperform rating and a price target of $79. Novarro says the company's Ziopatch product, which collects ECG data for up to 14 days, competes directly with traditional monitors and addresses several shortcomings of the current solutions. The analyst projects 40% revenue growth rate for the next 2 years "driven by market expansion, increased sales force productivity, and favorable reimbursement policies."
03/05/18
BMOC
03/05/18
INITIATION
Target $76
BMOC
Outperform
iRhythm initiated with an Outperform at BMO Capital
BMO Capital analyst Joanne Wuensch initiated iRhythm with an Outperform rating and a price target of $76. The analyst notes that the company's Holter monitor used to diagnose arrhythmias is "worn for longer periods of time and is more comfortable" while its data analytics improve the accuracy of the diagnostic. Wuensch believes that iRhythm is "one of the more interesting MedTech emerging growth stories" while also forecasting the company's clinical trials to expand the market opportunity.
02/15/18
JPMS
02/15/18
NO CHANGE
Target $67
JPMS
Overweight
iRhythm price target raised to $67 from $62 at JPMorgan
JPMorgan analyst Michael Weinstein raised his price target for iRhythm to $67 saying the company posted an "impressive close" to 2017. The analyst believes 2018 is setting up to be another "beat and raise year" and he reiterates an Overweight rating on the shares.
GNCA Genocea
$1.03

0.02 (1.98%)

03/05/18
CANT
03/05/18
INITIATION
Target $5
CANT
Overweight
Genocea initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated Genocea with an Overweight and $5 price target.
02/12/18
02/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. First Solar (FSLR) initiated with an Underperform at Credit Suisse. The firm also started SunPower (SPWR) with a Neutral and Sunrun (RUN) with an Outperform. 2. Genocea (GNCA) initiated with an Outperform at Baird. 3. Tetraphase (TTPH) initiated with a Buy at B. Riley FBR. 4. Aspen Group (ASPU) initiated with a Buy at Craig-Hallum. 5. Vermilion Energy (VET) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
BARD
02/12/18
INITIATION
Target $3
BARD
Outperform
Genocea initiated with an Outperform at Baird
Baird analyst Michael Ulz initiated Genocea with an Outperform rating citing its differentiated neoantigen-discovery platform. He views its ATLAS program as an alternative approach to identifying the neo-antigens with the potential to drive improved immune responses. Ulz has a $3 price target on Genocea shares.
03/06/18
CANT
03/06/18
NO CHANGE
Target $5
CANT
Overweight
Cantor starts Genocea with Overweight rating, $5 price target
Cantor Fitzgerald analyst Mara Goldstein last night initiated Genocea Biosciences with an Overweight rating and $5 price target. The company's pivot to neoantigen vaccines from infectious disease has pressured the valuation, but the current share price provides an opportunity for investors to participate in a potential platform change in oncology, Goldstein told investors in a research note. She believes neoantigen vaccines are at the forefront of cancer vaccine technology.
DPZ Domino's Pizza
$221.25

1.64 (0.75%)

03/05/18
BARD
03/05/18
INITIATION
BARD
Outperform
Domino's Pizza initiated with an Outperform at Baird
03/06/18
BARD
03/06/18
INITIATION
Target $260
BARD
Outperform
Domino's Pizza initiated with an Outperform rating, $260 target at Baird
As reported previously, Baird analyst David Tarantino initiated Domino's Pizza with an Outperform rating as he believes the company is well positioned to capitalize on a visible longer-term growth opportunity within the sizable and fragmented global pizza category. He also sees the potential for solid operating momentum in 2018 supporting positive investors sentiment. Tarantino has a $260 price target on Domino's Pizza shares.
02/27/18
OPCO
02/27/18
NO CHANGE
Target $75
OPCO
Outperform
Papa John's a more logical target for Restaurant Brands, says Oppenheimer
Oppenheimer analyst Brian Bittner says that while Domino's Pizza (DPZ) has been the center of speculation, his analysis suggests Papa John's (PZZA) represents the most logical target for Restaurant Brands (QSR). The analyst points out that Domino's Pizza larger size and valuation would require a major equity raise whereas Papa John's could be fully-funded internally by cash and pro-forma leverage. Domino's Pizza fundamentals are best-in-class, but Papa John's anatomy better fits Restaurant Brands' deal characteristics, he contends. Bittner reiterates an Outperform rating and $75 price target on Restaurant Brands' shares.
02/21/18
FBCO
02/21/18
NO CHANGE
Target $245
FBCO
Outperform
Domino's Pizza price target raised to $245 from $235 at Credit Suisse
Credit Suisse analyst Jason West raised his price target for Domino's Pizza (DPZ) to $245 from $235 following quarterly results. Commenting on a report by the Brazil Journal regarding a potential acquisition by Restaurant Brands (QSR), West says he continues to believe that a merger is unlikely. The analyst reiterates an Outperform rating on Domino's Pizza shares.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

, GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

19:35
03/24/19
03/24
19:35
03/24/19
19:35
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

NFLX

Netflix

$361.00

-17.09 (-4.52%)

AMZN

Amazon.com

$1,764.96

-53.49 (-2.94%)

AMD

AMD

$26.43

-1.47 (-5.27%)

SNE

Sony

$42.09

-1.915 (-4.35%)

GME

GameStop

$10.57

0.03 (0.28%)

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

CMCSK

Comcast

$0.00

(0.00%)

SABR

Sabre

$21.02

-0.62 (-2.87%)

MAN

Manpower

$80.83

-5.02 (-5.85%)

WBS

Webster Financial

$48.90

-3.03 (-5.83%)

NATI

National Instruments

$44.16

-1.28 (-2.82%)

JCOM

j2 Global

$84.63

-1.95 (-2.25%)

IIPR

Innovative Industrial Properties

$90.00

-0.175 (-0.19%)

CAT

Caterpillar

$129.80

-4.1 (-3.06%)

LYFT

Lyft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 04

    Apr

  • 16

    Apr

  • 18

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 10

    May

  • 12

    Jun

  • 27

    Oct

  • 29

    Mar

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

, GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

19:26
03/24/19
03/24
19:26
03/24/19
19:26
Periodicals
YouTube cancels plans for high-end dramas, comedies, Bloomberg reports »

Google-owned (GOOG;…

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

NFLX

Netflix

$361.00

-17.09 (-4.52%)

AMZN

Amazon.com

$1,764.96

-53.49 (-2.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 29

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

ENTG

Entegris

$34.64

-1.2 (-3.35%)

19:23
03/24/19
03/24
19:23
03/24/19
19:23
Hot Stocks
Taiwan court finds Gudeng Precision infringes Entegris' reticle pod patent »

Entegris received an oral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MGTA

Magenta Therapeutics

$18.77

0.805 (4.48%)

19:21
03/24/19
03/24
19:21
03/24/19
19:21
Downgrade
Magenta Therapeutics rating change at Goldman Sachs »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$31.03

-0.05 (-0.16%)

, CMCSA

Comcast

$39.56

-0.49 (-1.22%)

16:20
03/24/19
03/24
16:20
03/24/19
16:20
Hot Stocks
Box Office Battle: 'Us' soars to historic $70M U.S. debut »

Comcast (CMCSA, CMCSK)…

T

AT&T

$31.03

-0.05 (-0.16%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$42.09

-1.915 (-4.35%)

LGF.A

Lionsgate

$15.14

-0.7 (-4.42%)

DIS

Disney

$108.30

-0.36 (-0.33%)

VIAB

Viacom

$25.27

-0.7 (-2.70%)

VIA

Viacom

$30.64

-0.66 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 07

    May

  • 08

    May

  • 20

    May

  • 06

    Jun

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

16:07
03/24/19
03/24
16:07
03/24/19
16:07
Periodicals
Not enough evidence Trump obstructed justice, conspired with Russia, CNBC says »

Attorney General William…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

15:58
03/24/19
03/24
15:58
03/24/19
15:58
Periodicals
Mueller finds no Trump campaign-Russia conspiracy, Reuters reports »

Special Counsel Robert…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$119.21

-3.85 (-3.13%)

15:35
03/24/19
03/24
15:35
03/24/19
15:35
Hot Stocks
Ascendis Pharma announces top-line results from Phase 3 heiGHt trial »

Ascendis Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

12:50
03/24/19
03/24
12:50
03/24/19
12:50
Periodicals
Trump, lawmakers awaiting details of Mueller's report, Reuters says »

U.S. lawmakers drew…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

12:44
03/24/19
03/24
12:44
03/24/19
12:44
Periodicals
China refusing to concede on U.S. demands to ease curb on tech companies,FT says »

China is refusing to…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$175.60

-5.785 (-3.19%)

12:37
03/24/19
03/24
12:37
03/24/19
12:37
Periodicals
Alibaba acquires Israeli AR startup, Bloomberg reports »

Alibaba has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

12:34
03/24/19
03/24
12:34
03/24/19
12:34
Periodicals
Bayer CEO says team retains backing if supervisory board, Reuters says »

Bayer's management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

AAL

American Airlines

$30.60

-0.83 (-2.64%)

, BA

Boeing

$362.15

-10.54 (-2.83%)

12:31
03/24/19
03/24
12:31
03/24/19
12:31
Periodicals
American Airlines extends Boeing 737 Max flight cancellations, Reuters says »

American Airlines (AAL)…

AAL

American Airlines

$30.60

-0.83 (-2.64%)

BA

Boeing

$362.15

-10.54 (-2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

UBER

Uber

$0.00

(0.00%)

12:27
03/24/19
03/24
12:27
03/24/19
12:27
Periodicals
Uber to announce $3.1B deal to buy Careem, Bloomberg says »

Uber is set to announce a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$18.92

-0.39 (-2.02%)

12:17
03/24/19
03/24
12:17
03/24/19
12:17
Hot Stocks
Radius presents analysis from Phase 3 ACTIVE trial, data from TYMLOS studies »

Radius Health presented a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$90.00

-0.175 (-0.19%)

13:09
03/23/19
03/23
13:09
03/23/19
13:09
Periodicals
Innovative Industrial Properties flying high, Barron's says »

American cannabis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$129.80

-4.1 (-3.06%)

13:05
03/23/19
03/23
13:05
03/23/19
13:05
Periodicals
Investors missing how far Caterpillar dug into costs, Barron's says »

Caterpillar has made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

MO

Altria Group

$55.90

-0.23 (-0.41%)

12:59
03/23/19
03/23
12:59
03/23/19
12:59
Periodicals
E-cigarettes not helping people quit smoking, Barron's says »

According to the CDC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

MAN

Manpower

$80.83

-5.02 (-5.85%)

, SABR

Sabre

$21.02

-0.62 (-2.87%)

12:51
03/23/19
03/23
12:51
03/23/19
12:51
Periodicals
Sabre, j2 Global among mid-cap stocks with sustainable dividends, Barron's says »

When it comes to…

MAN

Manpower

$80.83

-5.02 (-5.85%)

SABR

Sabre

$21.02

-0.62 (-2.87%)

WBS

Webster Financial

$48.90

-3.03 (-5.83%)

NATI

National Instruments

$44.16

-1.28 (-2.82%)

JCOM

j2 Global

$84.63

-1.95 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 10

    May

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

, GME

GameStop

$10.57

0.03 (0.28%)

12:47
03/23/19
03/23
12:47
03/23/19
12:47
Periodicals
Gaming meets the cloud as investors scramble to catch up, Barron's says »

The cloud will eventually…

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

GME

GameStop

$10.57

0.03 (0.28%)

AMD

AMD

$26.43

-1.47 (-5.27%)

SNE

Sony

$42.09

-1.915 (-4.35%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 29

    Mar

  • 02

    Apr

  • 04

    Apr

  • 16

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

LYFT

Lyft

$0.00

(0.00%)

12:42
03/23/19
03/23
12:42
03/23/19
12:42
Periodicals
Investors should avoid booking ride when Lyft goes public, Barron's says »

Lyft will soon be going…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

DIS

Disney

$108.30

-0.36 (-0.33%)

, AAPL

Apple

$191.11

-3.96 (-2.03%)

12:38
03/23/19
03/23
12:38
03/23/19
12:38
Periodicals
Streaming revolution too complicated, Barron's says »

The streaming revolution…

DIS

Disney

$108.30

-0.36 (-0.33%)

AAPL

Apple

$191.11

-3.96 (-2.03%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 11

    Apr

  • 25

    Apr

  • 08

    May

FB

Facebook

$164.25

-1.83 (-1.10%)

, GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

08:18
03/23/19
03/23
08:18
03/23/19
08:18
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

FB

Facebook

$164.25

-1.83 (-1.10%)

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

TWTR

Twitter

$32.98

0.37 (1.13%)

GM

General Motors

$36.51

-0.84 (-2.25%)

AMD

AMD

$26.43

-1.47 (-5.27%)

INTC

Intel

$53.20

-1.41 (-2.58%)

MRVL

Marvell

$19.69

-1.11 (-5.34%)

MCHP

Microchip

$85.50

-1.83 (-2.10%)

MU

Micron

$41.68

-2.32 (-5.27%)

NVDA

Nvidia

$177.40

-6.52 (-3.55%)

QCOM

Qualcomm

$56.71

-1.05 (-1.82%)

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

  • 04

    Jun

  • 05

    Jun

  • 27

    Oct

21:30
03/22/19
03/22
21:30
03/22/19
21:30
General news
Breaking General news story  »

Chicago Federal Reserve…

21:15
03/22/19
03/22
21:15
03/22/19
21:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.